tiprankstipranks
Trending News
More News >
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market
Advertisement

NewAmsterdam Pharma Company (NAMS) Similar Stocks

Compare
198 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
NewAmsterdam Pharma Company
$23.42
$2.65B
35.77%
10 Buy
1 Hold
0 Sell
Strong Buy
Denali Therapeutics
$13.63
$1.99B
-44.09%
11 Buy
0 Hold
0 Sell
Strong Buy
Arcutis Biotherapeutics
$14.96
$1.78B
56.32%
7 Buy
1 Hold
0 Sell
Strong Buy
Harmony Biosciences Holdings
$35.76
$2.15B
14.30
5.74%
6 Buy
1 Hold
1 Sell
Moderate Buy
Recursion Pharmaceuticals
$6.31
$2.80B
-22.95%
1 Buy
4 Hold
0 Sell
Hold
Metsera, Inc.
$39.43
$4.14B
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NAMS
NewAmsterdam Pharma Company
23.42
7.24
44.75%
DNLI
Denali Therapeutics
13.63
-10.58
-43.70%
ARQT
Arcutis Biotherapeutics
14.96
5.33
55.35%
HRMY
Harmony Biosciences Holdings
35.76
1.89
5.58%
RXRX
Recursion Pharmaceuticals
6.31
-1.64
-20.63%
MTSR
Metsera, Inc.
39.43
11.63
41.83%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis